- Home
- TXRH vs RPRX Comparison
TXRH vs RPRX Comparison
Compare TXRH & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXRH | RPRX |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 16.2B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TXRH | RPRX |
|---|---|---|
| Price | $169.82 | $38.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $189.47 | $45.75 |
| AVG Volume (30 Days) | 824.9K | ★ 4.0M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | 1.62% | ★ 2.29% |
| EPS Growth | ★ 12.56 | N/A |
| EPS | ★ 6.55 | 1.75 |
| Revenue | ★ $5,833,958,000.00 | $2,349,844,000.00 |
| Revenue This Year | $11.90 | $37.13 |
| Revenue Next Year | $10.41 | $1.48 |
| P/E Ratio | $25.68 | ★ $21.92 |
| Revenue Growth | ★ 14.40 | 3.70 |
| 52 Week Low | $148.73 | $24.05 |
| 52 Week High | $199.99 | $41.24 |
Technical Indicators
Market Signals| Indicator | TXRH | RPRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.06 | 48.04 |
| Support Level | $164.51 | $37.88 |
| Resistance Level | $170.80 | $38.93 |
| Average True Range (ATR) | 3.04 | 0.77 |
| MACD | -0.19 | -0.20 |
| Stochastic Oscillator | 35.99 | 25.14 |
Price Performance
Historical ComparisonAbout TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.